Le Lézard
Classified in: Health
Subject: AWD

Sarah A. Garner, M.D., is recognized by Continental Who's Who


DES MOINES, Iowa, Jan. 20, 2020 /PRNewswire/ -- Sarah A. Garner, M.D., is being recognized by Continental Who's Who as a Pinnacle Lifetime Achiever in the field of Medicine for her accomplishments as an Internal Medicine Physician at Methodist Plaza Internal Medicine.

Backed over twelve years of experience, Dr. Garner is a patient-preferred doctor in Polk County. She holds specialized training in CMS Stage 1, which increases the services she can offer patients and allows her to dedicate more time to those she serves. She has special interest in Internal Medicine and Geriatrics. Revered in her field, she has been asked to publish her research findings in QJM: International Journal of Medicine. In addition to her role at Methodist Plaza Internal Medicine, she is a hospitalist at Methodist Hospital.

To prepare for her career, Dr. Garner attended the University of Iowa where she earned a Bachelor of Science in biology. She then went on to pursue a Doctorate of Medicine at the University of Iowa School of Medicine, Carver College of Medicine. Her internal medicine residency was completed at Iowa Health Services. She is board certified by the American Board of Internal Medicine.

To remain abreast of the changes in her field, Dr. Garner maintains associations with the American College of Physicians, Iowa Medical Society, and Polk County Medical Society.

In her free time, Dr. Garner volunteers with the Boy Scouts of America. She has three sons who participate in this organization.

Dr. Garner dedicates this recognition to her sister, Katie Burns, DO.

For more information, please visit https://www.unitypoint.org/desmoines/default.aspx

Contact: Katherine Green, 516-825-5634 [email protected]

SOURCE Continental Who's Who


These press releases may also interest you

at 04:00
Cancer spreads from its primary tumor to other parts of the body via blood or the lymphatic system in a process termed 'metastasis'. This usually represents an advanced stage in the disease's progression and tends to be fatal. Therefore, preventing...

at 03:30
Vicore Pharma Holding (STO:VICO)Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid (C21) in IPFAdditional presentations include preclinical and translational data reflecting...

at 03:13
Orexo's Annual and Sustainability Report for 2023 has been published and can be downloaded at, www.orexo.com. The Swedish version of the Report is also available on the company's website in European Single Electronic Format (ESEF). A PDF version is...

at 03:05
Surge has just closed its second round of funding, raising ?7.5 million. The round was led by Eurazeo with the participation of Kima, Teampact, and MH Innov', as well as the support of historical funds Boutique Venture, HCVC, and 50 Partners Santé....

at 03:00
CSL Vifor is pleased that its partner Akebia Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults who...

at 03:00
An analysis by the World Wildlife Fund (WWF) suggests that the average person ingests as many as 5 grams of microplastics weekly ? that's the equivalent of eating a whole credit card. While the exact effects of plastics on human health are still...



News published on and distributed by: